Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q2 2017 · 10-Q
Revenue$131.81M$131.81M+9.0% vs Q2 2016 Net Income$7.47M$7.47M−71.1% vs Q2 2016 EPS Diluted$0.20$0.20−71.0% vs Q2 2016 Gross Profit$88,143,000+8.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$41,351,000+7.3% Free Cash Flowderived$38,498,000+14.4% Margins · derivedGross margin66.9%−0.6 pt vs Q2 2016
Operating margin13.6%−16.2 pt vs Q2 2016
Net margin5.7%−15.7 pt vs Q2 2016
ended Dec 31, 2016 · filed Feb 9, 2017 · 40 d after period end